> Inovio Pharmaceuticals ($INO) reported positive Phase IIb studies of its VGX-3100, announcing that in women with high grade cervical neoplasia, the immunotherapy produced killer T cells that were able to clear lesions and the HPV virus itself. Release
> Ann Arbor, MI-based NanoBio announced that its adjuvanted genital herpes vaccine candidate showed efficacy in guinea pigs. Statement
> IDK Biologika opened its first U.S. vaccine manufacturing plant in Rockville, MD. Announcement
> Abivax named Dr. Jean-Marc Steens its chief medical officer. Release